DelfanB,BahmaniM,HassanzadazarH,SakiK,Rafieian-KopaeiM, 2014.Identification of medicinal plants affecting on headaches and migraines in Lorestan Province, West of Iran,Asian Pac J Trop Med 7 S376 -9
BalarabeS,YunusaMA, 2016.Prevalence of migraine among medical students in Sokoto, North-Western Nigeria,Eur J Pharm Med Res 3 604 -8
MorilloLE,AlarconF,AranagaN,AuletS,ChapmanE,ConternoL, 2005.Prevalence of migraine in Latin America,Headache 45 106 -17
BigalME,LiptonRB, 2006.Modifiable risk factors for migraine progression,Headache 46 1334 -43
PasschierJ,De BooM,QuaakHZ,BrienenJA, 1996.Health-related quality of life of chronic headache patients is predicted by the emotional component of their pain,Headache 36 556 -60
NaegelS,HolleD,DesmarattesN,TheysohnN,DienerHC,KatsaravaZ, 2014.Cortical plasticity in episodic and chronic cluster headache,Neuroimage Clin 6 415 -23
NesbittAD,MarinJCA,TompkinsE,RuttledgeMH,GoadsbyPJ, .Initial use of a novel noninvasive, -
SilbersteinSD,CalhounAH,LiptonRB,GrosbergBM,CadyRK,DorlasS, 2016.Chronic migraine headache prevention with noninvasive vagus nerve stimulation: the EVENT study,Neurology 87 529 -38
HeadacheClassification, 2013.Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version),Cephalalgia 33 629 -808
Al-HashelJY,AhmedSF,AlroughaniR,GoadsbyPJ, 2014.Migraine among medical students in Kuwait University,J Headache Pain 15 26 -
Tfelt-HansenP,PascualJ,RamadanN,DahlöfC,D'AmicoD,DienerHC, 2012.Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators,Cephalalgia 32 6 -38
TepperS,AshinaM,ReuterU,BrandesJL,DoležilD,SilbersteinS, 2017.Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebocontrolled phase 2 trial,Lancet Neurol 16 425 -34
2004.Headache Classification Subcommittee of the International Headache Society,The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 9 -160
HansenJM,ThomsenLL,OlesenJ,AshinaM., 2008.Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype,Neurology 71 841 -7
NorrisS,AtkinsD,BrueningW, 2010.Selecting observational studies for comparing medical interventions,In: Agency for Healthcare Research and Quality. Methods Guide for Comparative Effectiveness Reviews [posted June -
HigginsJ,GreenS, 2011.,Cochrane handbook for systematic reviews of interventions. Version 5.1.0 -
ChouR,AronsonN,AtkinsD,IsmailaAS,SantaguidaP,SmithDH, 2010.AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program,J Clin Epidemiol 63 502 -12
HigginsJP,AltmanDG,GøtzschePC,JüniP,MoherD,OxmanAD, 2011.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials,BMJ 343 d5928 -
van der VeldeG,van TulderM,CôtéP,HoggJohnsonS,AkerP,CassidyJD, 2007.The sensitivity of review results to methods used to appraise and incorporate trial quality into data synthesis,Spine (Phila Pa 32 796 -806
HerbisonP,Hay-SmithJ,GillespieWJ, 2006.Adjustment of meta-analyses on the basis of quality scores should be abandoned,J Clin Epidemiol 59 1249 -56
Ad, 1962.Hoc Committee on Classification of Headache. Classification of headache,JAMA 179 717 -8
TreadwellJR,UhlS,TiptonK,ShamliyanT,ViswanathanM,BerkmanND, 2012.Assessing equivalence and noninferiority,J Clin Epidemiol 65 1144 -9